IL-18 and IFN-γ are both pro-inflammatory cytokines, and both can exert anti-tumor effects by promoting the production of anti-cancer cytokines and enhancing the killing of tumors by immune cells [15,25,26]. The gene discussed is IL18; the disease is cancer.